Cooling Helmets for Concussion
(ColdCon Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether cooling helmets can improve recovery from mild concussions, a type of mild brain injury. Emergency room visitors with a recent concussion will either receive usual care or try a helmet that cools the head and neck, known as the Catalyst Cryohelmet. The trial aims to determine if the cooling helmet reduces symptoms like headaches and accelerates recovery. Individuals who experienced a concussion within the last 24 hours and are not severely injured may be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance recovery for future patients.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the Catalyst Cryohelmet is safe for treating mild traumatic brain injuries?
Research has shown that cooling the head and neck, such as with the Catalyst Cryohelmet, is safe for people. A study with healthy volunteers found that this cooling method did not cause any harmful side effects. Additionally, research from New Zealand found that using the Cryohelmet greatly reduced symptoms in people with sports-related concussions.
These findings suggest that the Cryohelmet is generally well-tolerated. However, the trial is in an early stage, so more research is needed to fully understand its safety and effectiveness in treating mild traumatic brain injuries.12345Why are researchers excited about this trial?
Researchers are excited about the Catalyst Cryohelmet because it offers a unique approach to treating concussions by combining standard symptomatic care with targeted cooling therapy. Unlike traditional treatments that solely rely on medications like acetaminophen or anti-nausea drugs, the Cryohelmet uses head-neck cooling to potentially reduce symptoms more effectively and quickly. This cooling method may help minimize inflammation and other post-concussion effects, offering a novel mechanism that could enhance recovery compared to current options.
What evidence suggests that the Catalyst Cryohelmet is effective for mild TBI?
Research has shown that cooling the head and neck can aid recovery from mild traumatic brain injuries, such as concussions. In this trial, one group of participants will receive symptomatic care along with the use of the Catalyst Cryohelmet for head-neck cooling. One study found that the Catalyst Cryohelmet quickly reduced concussion symptoms after a head injury. This cooling method appears to lessen symptom severity and may speed up recovery. Another study showed that cooling helmets decreased both the number and severity of symptoms after a sports-related concussion. These findings suggest that the Catalyst Cryohelmet could effectively reduce symptoms following a concussion.12346
Are You a Good Fit for This Trial?
This trial is for individuals aged 19-65 who've had a mild traumatic brain injury with symptoms like headaches within the first day of injury. They must have a Glasgow Coma Scale score over 13 and be able to consent. It's not for pregnant women, those with certain medical conditions, or severe migraines.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive symptomatic care and 30 minutes of head-neck cooling in the emergency department
Follow-up
Participants are monitored for safety and effectiveness after treatment using the Post-Concussion Symptom Severity Score Index
What Are the Treatments Tested in This Trial?
Interventions
- Catalyst Cryohelmet
Find a Clinic Near You
Who Is Running the Clinical Trial?
Spectrum Health - Lakeland
Lead Sponsor